Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Doral, Fredericks"'
Autor:
Doral Fredericks, Clive Ballard, Alberto J. Espay, Candace Andersson, Michael T. Guskey, Bruce Coate, Stewart A. Factor, Niccole J. Larsen, James C. Norton, Joseph H. Friedman, Joaquin A. Vizcarra, Daniel Weintraub, Anthony E. Lang
Publikováno v:
Movement Disorders. 33:1769-1776
Background: PD psychosis is often associated with cognitive impairment, including dementia, and involves dopaminergic, serotonergic, and cholinergic mechanisms. Objective: To evaluate the differential effect of the antipsychotic pimavanserin, a selec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d8d89cb1305a4edd030d0b54ab0001b
https://doi.org/10.1002/mds.27488
https://doi.org/10.1002/mds.27488
Autor:
Alberto J, Espay, Michael T, Guskey, James C, Norton, Bruce, Coate, Joaquin A, Vizcarra, Clive, Ballard, Stewart A, Factor, Joseph H, Friedman, Anthony E, Lang, Niccole J, Larsen, Candace, Andersson, Doral, Fredericks, Daniel, Weintraub
Publikováno v:
Movement Disorders
Background: PD psychosis is often associated with cognitive impairment, including dementia, and involves dopaminergic, serotonergic, and cholinergic mechanisms. Objective: To evaluate the differential effect of the antipsychotic pimavanserin, a selec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::082564c1954715c6bc10dd532616186a
https://pubmed.ncbi.nlm.nih.gov/30387904
https://pubmed.ncbi.nlm.nih.gov/30387904
Autor:
Kaitlin Healy, Andrew Shim, Amy Ryan, Doral Fredericks, Jeffrey Trotter, Susan H. Fox, Jennifer G. Goldman, Stuart Isaacson
Publikováno v:
The American Journal of Geriatric Psychiatry. 27:S221-S222
Introduction Parkinson's disease is the second most common neurodegenerative disease, and over half of patients diagnosed will experience the symptoms of psychosis at some point during the course of the disease. Despite the prevalence of Parkinson's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdf39dd9ffd36bc67ebe6816e0de007a
https://doi.org/10.1016/j.jagp.2019.01.134
https://doi.org/10.1016/j.jagp.2019.01.134
Publikováno v:
The American journal of managed care. 23
Parkinson's disease (PD) is a progressive neurodegenerative disease associated with a decrease in the neurotransmitter dopamine and characterized by the cardinal motor hallmarks of resting tremor, rigidity, bradykinesia/akinesia, and postural instabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f67031dbd0562ca2fe413f1cd77f6cc0
https://pubmed.ncbi.nlm.nih.gov/28715903
https://pubmed.ncbi.nlm.nih.gov/28715903
Publikováno v:
CNS Spectrums. 23:84-85
Study ObjectivePsychosis is common in Parkinson’s disease (PD) and increases in both frequency and severity with disease duration. It is associated withincreased morbidity/mortality, complicates management of motor symptoms and often leads to long-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa444f245c50969af20df034d3d8a490
https://doi.org/10.1017/s1092852918000317
https://doi.org/10.1017/s1092852918000317
Publikováno v:
The American Journal of Geriatric Psychiatry. 25:S148-S149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9301582022be7e476aacc101da433d32
https://doi.org/10.1016/j.jagp.2017.01.173
https://doi.org/10.1016/j.jagp.2017.01.173
Autor:
Daniel Weintraub, Clive Ballard, James C. Norton, Doral Fredericks, Bruce Coate, Candace Andersson
Publikováno v:
CNS Spectrums. 23:77-77
ObjectiveA planned subgroup analysis of a phase 3 study was performed to evaluate the efficacy and safety of pimavanserin (PIM) in Parkinson’s disease psychosis (PDP) patients withglobal cognitive impairment.BackgroundPDP is frequent, distressing,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cbd99b6f27744b8ca91ff24f1614eb7
https://doi.org/10.1017/s1092852918000202
https://doi.org/10.1017/s1092852918000202
Publikováno v:
European Neurological Review. 12:92
Over half of patients with Parkinson’s disease (PD) develop symptoms of psychosis during the course of their disease. Existing guidelines include recommendations for managing symptoms of psychosis in patients with PD. However, the extent to which s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09cb2a37fb0b52dbd33ac48b0c94d4ea
https://doi.org/10.17925/enr.2017.12.02.92
https://doi.org/10.17925/enr.2017.12.02.92
Publikováno v:
European Neurological Review. 12:87
Parkinson’s disease psychosis (PDP) is a clinical condition that affects patients diagnosed with Parkinson’s disease (PD) and has a spectrum of neuropsychiatric symptoms distinct from the hallmark motor symptoms. Although prior studies have repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e13fc843b46ce45ec4da247eda2e683
https://doi.org/10.17925/enr.2017.12.02.87
https://doi.org/10.17925/enr.2017.12.02.87